Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd CRISPR-Based Therapy Analytical Development Summit

Evvnt Promotion / evvnt
-
17.09.2024 - 19.09.2024  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Temi della conferenza
As CRISPR-based therapies become ever complex, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny, with the FDA closely studying off-target analysis conducted ahead of the approval of Casgevy, prior to finalizing guidance on genome editing therapies in January.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2433843-3?pid=4832

Speakers: Andrew Kernytsky, Principal Consultant, Next Gen Editing, Bryant Chia, Scientist, Analytical Chemistry and Structural Biology, Editas Medicine, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2433843-2?pid=4832
Ms. Jasmine Fletcher
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5796.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Österreichische Akademie der ÄrzteCharité International AcademyEuropean Health Forum GasteinÄrztekammer für WienHilfswerk AustriaSwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.AGEM - Arbeitsgemeinschaft Ethnologie und Medizin